"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events
about
Economic analysis of pandemic influenza vaccination strategies in Singapore.Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemicGuillain-Barré syndrome following H1N1 immunization in a pediatric patient.Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.Vaccination of health-care workers against influenza: our obligation to protect patients.No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodiesInfluenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes[Guillain-Barré syndrome after exposure to influenza].Influenza-associated neurological complications.Vaccinations in patients with immune-mediated inflammatory diseasesOntology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.Surveillance of adverse effects following vaccination and safety of immunization programs.Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.HLA-DRB1 the notorious gene in the mosaic of autoimmunity.High incidence of Guillain-Barre syndrome in children, Bangladesh.Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA).
P2860
Q30380974-0B9DBCE1-AACB-4017-BD42-9CA4FA900D4CQ30383451-6231BC17-8AEF-4B48-A683-E76B290F36DBQ30389390-3DD044A0-6986-4056-968C-A7EA143A0C96Q30389582-C465C0DA-D59F-49F6-A936-6C03E5A660C0Q30403785-23954490-336B-4BC0-A44C-AB8D0C6048F9Q30407561-AFF69B02-CD6F-4249-A1EB-276996A900D5Q30409462-3C7AC93A-256A-4954-A60B-B0D31A9DAD23Q30415924-8229B5D8-4F3A-47EE-838B-97D7C6B1C174Q30423370-50C2B97E-E83E-407E-9DB9-77C537F71081Q34117134-2C2F5CB5-416E-49F8-8119-A7F88FE84091Q34499848-2C379D80-34D4-4117-8A44-8949601CCD16Q37823382-B5FD90EC-C242-4CBB-8DBF-7302C3F73E94Q37878862-ABE1DEFB-22D6-4AEC-B1C6-F2AF77D4F194Q40607323-47BB0F8B-F148-4516-BF93-8B98235F68A4Q43203710-249D2A36-55B7-471C-948C-D34D8C043D6AQ51369030-BEC389DD-B152-45CC-A0F3-6ECA3F377B9EQ52593678-5BDC1E6B-B291-47D4-8298-8D80CB0DAD5AQ55058719-F0619EC6-E07B-4D9C-95C6-FBCD4267727E
P2860
"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
"Prepandemic" immunization for ...... of rare severe adverse events
@ast
"Prepandemic" immunization for ...... of rare severe adverse events
@en
type
label
"Prepandemic" immunization for ...... of rare severe adverse events
@ast
"Prepandemic" immunization for ...... of rare severe adverse events
@en
prefLabel
"Prepandemic" immunization for ...... of rare severe adverse events
@ast
"Prepandemic" immunization for ...... of rare severe adverse events
@en
P2860
P356
P1476
"Prepandemic" immunization for ...... of rare severe adverse events
@en
P2093
David Evans
P2860
P304
P356
10.1086/603560
P407
P577
2009-08-01T00:00:00Z